Breaking deals, patent filings, policy shifts, and technology transfer milestones — curated from 200+ sources across 50 countries. Updated continuously.
In one of the largest industrial IP transactions of 2024, Microsoft and Siemens have finalized a comprehensive cross-licensing framework covering 4,800 patents spanning industrial automation, AI inference systems, and edge computing. The deal includes a $3.2B upfront payment and a revenue-sharing structure tied to licensing revenue from third parties, with both parties granting royalty-free access for internal R&D use. Legal teams from Freshfields and Covington & Burling advised on the transaction.
The Supreme Court's unanimous decision in TechVenture v. USPTO has clarified that AI-assisted inventions require demonstrable human creative contribution at each step of the inventive process to qualify for patent protection — a ruling that affects an estimated 340,000 pending applications.
The European Commission has published a draft regulation reducing Unified Patent Court fees by 40% for SMEs and first-time applicants, as part of the EU's broader Innovation Equity initiative. The proposal covers 24 member states and takes effect January 2025 pending Council approval.
Taiwan Semiconductor Manufacturing Company has executed a $890M licensing agreement granting Samsung, SK Hynix, and DB HiTek access to 320 patents covering CoWoS, SoIC, and InFO advanced packaging technologies. The deal marks TSMC's first major third-party packaging IP license and includes a 10-year term with revenue escalators.
A team from MIT's Research Laboratory of Electronics has spun out Lumavolt Corp to commercialize a proprietary tandem perovskite-silicon solar cell manufacturing process. The company's 48-patent portfolio, valued by independent analysts at $420M, is already licensed to three European module manufacturers ahead of Series A funding.
WIPO's annual Global Innovation Report shows total IP licensing revenue reached $450B globally in 2024, up 11.4% year-over-year. Software IP accounted for 38% of all revenue, followed by pharmaceuticals (29%) and semiconductor IP (17%). Asia-Pacific overtook Europe as the second-largest regional market for the first time.
Bessemer Venture Partners has closed a $1.2B structured credit fund that uses portfolio company IP as primary collateral, marking the first institutional-scale IP-backed lending vehicle from a top-tier VC firm. The fund will provide non-dilutive capital to 40–60 portfolio companies, with patent portfolios independently assessed using AI-assisted valuation tools.
China's National Intellectual Property Administration has published revised guidelines requiring all SEP holders operating in Chinese markets to file detailed disclosure statements within 90 days of standard adoption. The rules affect approximately 8,500 declared SEPs in 5G, Wi-Fi 7, and USB4 standards and are expected to reduce FRAND litigation by establishing clearer valuation baselines.
Oxford's Technology Transfer office has executed a comprehensive licensing agreement granting Moderna exclusive rights to its lipid nanoparticle delivery platform patents for oncology applications. The deal includes $120M upfront, $440M in development and sales milestones, and tiered royalties. The agreement is IEM's largest university-to-corporate transaction of 2024.
DARPA's Technology Transfer Acceleration Program has made 1,400 patents available for non-exclusive licensing under simplified terms. The portfolio spans advanced materials, quantum sensing, autonomous systems, and biodefense — with fees waived for first year for qualified US-based startups. Licensing applications open January 15.
India's revised National IP Rights Policy now allows public research institutions to retain 75% of patent licensing revenue, up from 30% under the previous framework. The amendment, modeled on the Bayh-Dole Act, is expected to accelerate commercialization of the 12,000+ patents held by Indian IITs and CSIR laboratories.